当前位置:首页 - 行情中心 - 华森制药(002907) - 财务分析 - 现金流量表

华森制药

(002907)

  

流通市值:45.44亿  总市值:63.27亿
流通股本:3.00亿   总股本:4.18亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金614,186,041.27410,213,008.49184,687,189.98759,844,821.05
  收到的税费返还1,438,103.711,438,103.711,438,103.713,723,287.02
  收到其他与经营活动有关的现金22,545,578.8512,246,976.575,549,959.8236,405,297.53
  经营活动现金流入小计638,169,723.83423,898,088.77191,675,253.51799,973,405.6
  购买商品、接受劳务支付的现金218,495,293.33130,299,225.3739,134,249.76183,945,279.88
  支付给职工以及为职工支付的现金121,601,818.1281,835,620.8348,068,885.95147,061,248.09
  支付的各项税费80,968,255.4157,981,836.7122,689,056.9984,545,592.49
  支付其他与经营活动有关的现金192,311,937.1126,255,067.2259,922,117.76222,654,476.12
  经营活动现金流出小计613,377,303.96396,371,750.13169,814,310.46638,206,596.58
  经营活动产生的现金流量净额24,792,419.8727,526,338.6421,860,943.05161,766,809.02
二、投资活动产生的现金流量:
  收回投资收到的现金550,000,000230,000,000120,000,000344,653,775.24
  取得投资收益收到的现金5,349,047.491,781,185.51,203,411.523,874,331.16
  处置固定资产、无形资产和其他长期资产收回的现金净额6,500,000--3,500
  投资活动现金流入小计561,849,047.49231,781,185.5121,203,411.52348,531,606.4
  购建固定资产、无形资产和其他长期资产支付的现金8,892,142.464,679,728.182,374,756.7316,151,133.15
  投资支付的现金690,000,000400,000,000300,000,000439,589,930.55
  取得子公司及其他营业单位支付的现金-447,333.24-447,333.24--
  投资活动现金流出小计698,444,809.22404,232,394.94302,374,756.73455,741,063.7
  投资活动产生的现金流量净额-136,595,761.73-172,451,209.44-181,171,345.21-107,209,457.3
三、筹资活动产生的现金流量:
  分配股利、利润或偿付利息支付的现金35,495,686.720,879,815.7-35,495,684.72
  支付其他与筹资活动有关的现金6,105,250.176,063,274.1728,800138,360
  筹资活动现金流出小计41,600,936.8726,943,089.8728,80035,634,044.72
  筹资活动产生的现金流量净额-41,600,936.87-26,943,089.87-28,800-35,634,044.72
四、汇率变动对现金及现金等价物的影响-179,691.37-131,580.48-136,374.9563,769.26
五、现金及现金等价物净增加额-153,583,970.1-171,999,541.15-159,475,577.1118,987,076.26
  加:期初现金及现金等价物余额456,551,895.4456,551,895.4456,552,929.38437,564,819.14
  期末现金及现金等价物余额302,967,925.3284,552,354.25297,077,352.27456,551,895.4
补充资料:
  净利润-52,286,443.02-76,730,225.12
  资产减值准备-240,732.9-3,495,457.14
  固定资产和投资性房地产折旧-33,639,802.44-68,715,305.37
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-33,639,802.44-68,715,305.37
  无形资产摊销-9,911,181.76-18,126,985.54
  长期待摊费用摊销-1,432,777.79-2,451,352.44
  固定资产报废损失-234,733.67-32,253.89
  公允价值变动损失--755,500.26--7,518,348.83
  财务费用-51,406.84--3,309,487.81
  投资损失--15,570,992.36-6,140,731.36
  递延所得税-14,316,058.55--766,316.82
  其中:递延所得税资产减少-2,079,830.95--1,594,090.42
    递延所得税负债增加-12,236,227.6-827,773.6
  存货的减少-19,379,383.69-10,588,748.99
  经营性应收项目的减少--76,328,150.38--30,297,824.64
  经营性应付项目的增加--11,382,777.22-17,279,047.44
  现金的期末余额-284,552,354.25-456,551,895.4
  减:现金的期初余额-456,551,895.4-437,564,819.14
  现金及现金等价物的净增加额--171,999,541.15-18,987,076.26
公告日期2025-10-292025-08-222025-04-252025-04-25
审计意见(境内)标准无保留意见
TOP↑